24 March 2020

Fight against COVID-19 fraud is new investigation priority of the US Department of Justice

The US Department of Justice (DOJ) has directed all US Attorneys to actively detect, deter and punish misconduct related to the COVID-19 Pandemic.

We live in challenging times. As if keeping the spreading Corona virus at bay were the only threat, more and more crisis profiteers are apparently trying their luck – essentially highlighting the necessity of a vigilant and responsive legal system. Please read our GSK Compliance update.

Print


Press contact
Christine Ström
+49 30 203907-7763
presse@gsk.de

Back

GSK Updates
  • 25 September 2020

    GSK Update: The Federal Assembly approves government draft bill on Law to strengthen Integrity in Business

    Read more
  • 01 September 2020

    GSK Update: Working during the coronavirus pandemic: As an employer, how do I deal with employees returning from holidays?

    Read more
  • 01 September 2020

    GSK Update: Modernisation of the LCIA Rules: A “light-touch” update

    Read more
Contact person

Eric Mayer

Local Partner*

+49 89 288174-73

eric.mayer@gsk.de

© GSK Stockmann 2020

* Partner: A partner within the meaning of the partnership company law.
   Local Partner: not a partner within the meaning of the partnership company law.
CO2 Neutral